Welcome to our dedicated page for Bwx Technologies news (Ticker: BWXT), a resource for investors and traders seeking the latest updates and insights on Bwx Technologies stock.
BWX Technologies, Inc. reports developments tied to its nuclear manufacturing, engineering, and services businesses for government and commercial customers. Recurring updates include U.S. Naval Nuclear Propulsion Program contracts, long-lead reactor and component manufacturing, commercial nuclear equipment, and work connected to nuclear fuel and uranium-enrichment capabilities.
Company news also covers operating and financial results for its Government Operations and Commercial Operations segments, capital actions, governance changes, and regulatory engagement involving nuclear licensing. BWXT’s recurring business themes span global security, clean energy, nuclear medicine, space exploration, and environmental restoration.
Lineage (NASDAQ: LINE) announced that Robb LeMasters will join as Chief Financial Officer effective November 10, 2025, succeeding Rob Crisci, who is retiring and will remain in an advisory role through a transition period. LeMasters brings more than two decades of finance and executive leadership experience, most recently serving as CFO of BWX Technologies and with prior roles in investment management and private equity.
Lineage also named Ki Bin Kim as Vice President of Investor Relations; Kim has over two decades of REIT equity research and capital markets experience and will lead global investor relations. For more information visit ir.onelineage.com.
NuScale Power (NYSE: SMR) named James D. Canafax as Chief Legal Officer and Corporate Secretary, effective October 20, 2025. Canafax brings decades of legal and compliance experience in nuclear, energy and manufacturing sectors, most recently as General Counsel and Chief Compliance Officer at Maritime Partners and previously as Senior VP, General Counsel and Corporate Secretary at BWX Technologies (NYSE: BWXT). His background includes managing M&A, high-profile litigation, and extensive engagement with the U.S. Nuclear Regulatory Commission, Department of Energy and Department of Defense. Canafax holds a JD from Harvard Law School, a BS in International Trade and Finance from LSU, and completed MIT’s Nuclear Reactor Technology Course for Executives.
BWX Technologies (NYSE: BWXT) will release its Q3 2025 results on Monday, November 3, 2025 after market close and will host a conference call the same day at 5:00 p.m. EST.
Listen-only participants can join via webcast at investors.bwxt.com or by phone: U.S. 1-800-715-9871, International 1-646-307-1963 (Conference ID: 2465821). A replay will be available on BWXT's website for a limited time.
BWXT is a U.S.-based nuclear manufacturing and engineering company with nearly 10,000 employees, serving the U.S. Department of Energy and NNSA across more than a dozen major North American contracts.
BWX Technologies (NYSE:BWXT) has secured a significant $1.6 billion, 10-year contract from the Department of Energy's National Nuclear Security Administration to establish a high purity depleted uranium (HPDU) manufacturing facility. The project, located in Jonesborough, Tennessee, will produce up to 300 metric tons of HPDU annually.
The contract scope includes plant design, licensing, equipment procurement, site preparation, and operational readiness. The facility will create 175 highly skilled jobs once fully operational and will be the only active site in the U.S. capable of performing this critical process for the government. The plant will focus on engineered environmental controls with no additional liquid discharge into local waterways.
Kinectrics, a division of BWX Technologies (NYSE:BWXT), has completed a major expansion of its isotope production capabilities in Toronto. The company has installed four new 2nd generation Electromagnetic Isotope Separator (EMIS) units, increasing its annual Ytterbium-176 (Yb-176) production capacity to over 500 grams, enough to support 150,000 patient treatments annually.
The expansion establishes Kinectrics as the only North American source for Yb-176, a crucial precursor for Lutetium-177 used in prostate cancer treatment. The project includes construction of a new 26,000-sq.-ft. facility scheduled for completion next year, supported by funding from the Canadian and Ontario governments. The company also plans to expand its portfolio to include Gadolinium-160 production later this year.
BWX Technologies (NYSE:BWXT) has secured a $1.5 billion contract from the National Nuclear Security Administration (NNSA) to establish domestic uranium enrichment capabilities for defense purposes. The company will build the Domestic Uranium Enrichment Centrifuge Experiment (DUECE) pilot plant in Erwin, Tennessee.
The project includes constructing a Centrifuge Manufacturing Development Facility in Oak Ridge, Tennessee, which began in June 2025. The pilot plant will initially demonstrate low-enriched uranium production before transitioning to produce highly enriched uranium for naval propulsion. The facility is expected to create 100 highly skilled jobs initially, with further growth anticipated during the manufacturing phase.
BWX Technologies (NYSE:BWXT) has appointed Rik Geiersbach as Chief Strategy Officer, reporting to CEO Rex Geveden. Geiersbach, who previously served as vice president of strategy and corporate development at Boeing, brings 30 years of experience in corporate growth strategy and market development.
At Boeing, Geiersbach managed the $30-billion Defense, Space and Security business unit's strategy, M&A, and R&D portfolios. Before Boeing, he held the position of corporate director of strategic alliances at Northrop Grumman. He holds an MBA from UCLA's Anderson School of Management and a bachelor's degree from Harvard University.
BWX Technologies (NYSE: BWXT) reported strong Q2 2025 results with revenues of $764.0 million, up 12% year-over-year. The company achieved net income of $78.5 million and adjusted EBITDA of $145.9 million.
Key highlights include the successful acquisition of Kinectrics, Inc., signing of a naval reactors pricing agreement worth over $1.0 billion, and reaching a record backlog of $6.0 billion, representing a 70.2% increase year-over-year. The company raised its 2025 guidance, now expecting adjusted EBITDA of $565-575 million and non-GAAP EPS of $3.65-3.75.
Both segments showed revenue growth, with Government Operations up 9% to $589.0 million and Commercial Operations up 24% to $176.1 million. Free cash flow significantly improved to $126.3 million, a 256% increase from the previous year.
BWX Technologies (NYSE: BWXT) has appointed Mike T. Fitzgerald as its permanent Chief Financial Officer, following his interim CFO role since May 12, 2025. Fitzgerald, who joined BWXT in 2022 as vice president of finance and chief accounting officer, brings significant experience from his previous roles at MorganFranklin's aerospace and defense practice and Deloitte & Touche.
The appointment comes after Fitzgerald's successful tenure as interim CFO, during which he demonstrated strong strategic vision and deep business understanding, according to BWXT CEO Rex Geveden. Notably, Fitzgerald received a rising star award from the Northern Virginia Technology Council in 2024 for his financial leadership at BWXT.
BWX Technologies (NYSE:BWXT) has begun manufacturing the reactor core for Project Pele, a 1.5-megawatt transportable microreactor for the Department of Defense. The innovative reactor, designed to fit in four 20-foot shipping containers, will provide reliable power for military bases for up to three years without refueling.
The project involves key partnerships with Rolls-Royce developing the power conversion module and Northrop Grumman providing the control module. The reactor will use TRISO fuel, a specialized HALEU fuel designed for extreme heat conditions. Project Pele aligns with Executive Order 14299, which mandates the operation of a nuclear reactor at a domestic military base by September 30, 2028.